MDR — Medadvisor Income Statement
0.000.00%
Last trade - 00:00
- AU$142.20m
- AU$132.30m
- AU$97.96m
- 36
- 60
- 86
- 64
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 9.19 | 11.1 | 40.3 | 67.8 | 98 |
Cost of Revenue | |||||
Gross Profit | 8.18 | 9.85 | 22.8 | 35 | 59.4 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 17.3 | 20.7 | 57.1 | 85.5 | 109 |
Operating Profit | -8.09 | -9.66 | -16.8 | -17.7 | -10.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -8.1 | -9.78 | -17.2 | -17.7 | -10.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -8.1 | -9.78 | -14.4 | -17.5 | -11.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -8.1 | -9.59 | -13.9 | -17.3 | -11.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -8.1 | -9.59 | -13.9 | -17.3 | -11.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.042 | -0.041 | -0.044 | -0.046 | -0.021 |